iX Biopharma (SGX:42C) announced on July 14 that it has allotted and issued 2,915,442 new ordinary shares, following the exercise of warrants, at an exercise price of 6 cents per share.

Out of the 2,915,442 new ordinary shares, 1,004,036 new ordinary shares are allotted and issued to Albert Ho Shing Tung, who is the company’s non-executive non-independent director and 15,301 new ordinary shares to Centrum Capital Pte Ltd, a company in which Ho has a deemed interest.

As a result of this latest exercise of warrants, iX Biopharma’s total number of issued shares has increased from 1,074,528,272 shares to 1,077,443,714 shares.

https://www.theedgesingapore.com/news/equity-raising/ix-biopharma-allots-close-292-mil-new-shares-following-warrant-exercise